Biotech R & D Startup Benchling Hits $4 Billion Valuation As The Company Starts Laying Groundwork For An IPO

Sajith Wickramasekara was just 24 when he made the Forbes 30 Under 30 list for his biotech R&D startup, Benchling. Now his company is worth $4 billion with a new $200 million round led by Sequoia.
Source: Forbes.com Healthcare News - Category: Pharmaceuticals Authors: Tags: Manufacturing /manufacturing Business /business Innovation /innovation Healthcare /healthcare Venture Capital /venture-capital Leadership /leadership Under 30 /under30 Enterprise Tech /enterprise-tech Editors' Pick editor Source Type: news